Literature DB >> 10050242

Epidemiology of Dupuytren's disease.

D C Ross1.   

Abstract

Studying the epidemiology of Dupuytren's disease allows the identification of populations at risk and may point to inferences regarding etiology. Data suggest the highest prevalence of the disease occurs in people of northern European stock. However, the disease does occur in nearly all populations examined. Dupuytren's disease occurs more frequently in men than women and becomes symptomatic approximately 10 years earlier in the lives of men than in women. Dupuytren's disease has been associated with a number of other diseases including seizure disorders, alcoholism, diabetes mellitus, and cigarette smoking. There is conflicting evidence as to whether manual labor or HIV seropositivity increases the prevalence of the disorder.

Entities:  

Mesh:

Year:  1999        PMID: 10050242

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  33 in total

Review 1.  Trends in the Treatment of Dupuytren Disease in the United States Between 2007 and 2014.

Authors:  Marc D Lipman; Samuel Evan Carstensen; Dylan Nicole Deal
Journal:  Hand (N Y)       Date:  2016-05-03

2.  Genome-wide association scan of Dupuytren's disease.

Authors:  Joshua O Ojwang; Indra Adrianto; Courtney Gray-McGuire; Swapan K Nath; Celi Sun; Kenneth M Kaufman; John B Harley; Ghazi M Rayan
Journal:  J Hand Surg Am       Date:  2010-10-25       Impact factor: 2.230

Review 3.  Management of Dupuytren's disease--clear advice for an elusive condition.

Authors:  A Bayat; D A McGrouther
Journal:  Ann R Coll Surg Engl       Date:  2006-01       Impact factor: 1.891

Review 4.  Dupuytren's contracture unfolded.

Authors:  W A Townley; R Baker; N Sheppard; A O Grobbelaar
Journal:  BMJ       Date:  2006-02-18

5.  Operative trends and physician treatment costs associated with Dupuytren's disease in Canada.

Authors:  Wendy Liu; David B O'Gorman; Bing Siang Gan
Journal:  Can J Plast Surg       Date:  2013

6.  Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II.

Authors:  Issei Komatsu; Jennifer Bond; Angelica Selim; James J Tomasek; L Scott Levin; Howard Levinson
Journal:  J Hand Surg Am       Date:  2010-10       Impact factor: 2.230

7.  Differential gene expression analysis of subcutaneous fat, fascia, and skin overlying a Dupuytren's disease nodule in comparison to control tissue.

Authors:  Barbara Shih; Jason J Brown; Daniel J Armstrong; Tommy Lindau; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2009-01-29

8.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

9.  Gender ratio of Dupuytren's disease in the modern U.S. population.

Authors:  Shawn G Anthony; Santiago A Lozano-Calderon; Barry P Simmons; Jesse B Jupiter
Journal:  Hand (N Y)       Date:  2007-09-07

10.  Modified percutaneous needle aponeurotomy for the treatment of dupuytren's contracture: early results and complications.

Authors:  Fernando A Herrera; Scott Mitchell; Mark Elzik; Jason Roostaeian; Prosper Benhaim
Journal:  Hand (N Y)       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.